Pellock J - Search Results

1

Pharmacokinetics of diazepam administered intramuscularly by autoinjector versus rectal gel in healthy subjects: a phase I, randomized, open-label, single-dose, crossover, single-centre study.

Lamson MJ, Sitki-Green D, Wannarka GL, Mesa M, Andrews P, Pellock J. Lamson MJ, et al. Among authors: pellock j. Clin Drug Investig. 2011;31(8):585-597. doi: 10.2165/11590250-000000000-00000. Clin Drug Investig. 2011. PMID: 21721594 Clinical Trial.

2

Respiratory adverse events associated with diazepam rectal gel.

Pellock JM, Shinnar S. Pellock JM, et al. Neurology. 2005 May 24;64(10):1768-70. doi: 10.1212/01.WNL.0000162031.03390.BA. Neurology. 2005. PMID: 15911807

3

Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled study.

Mann D, Liu J, Chew ML, Bockbrader H, Alvey CW, Zegarac E, Pellock J, Pitman VW. Mann D, et al. Among authors: pellock j. Epilepsia. 2014 Dec;55(12):1934-43. doi: 10.1111/epi.12830. Epub 2014 Nov 6. Epilepsia. 2014. PMID: 25377429 Free article. Clinical Trial.

4

Safety of rapid intravenous valproate infusion in pediatric patients.

Morton LD, O'Hara KA, Coots BP, Pellock JM. Morton LD, et al. Pediatr Neurol. 2007 Feb;36(2):81-3. doi: 10.1016/j.pediatrneurol.2006.11.003. Pediatr Neurol. 2007. PMID: 17275657 Clinical Trial.

5

Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.

Shinnar S, Pellock JM, Conry JA. Shinnar S, et al. Eur J Paediatr Neurol. 2009 Jan;13(1):3-9. doi: 10.1016/j.ejpn.2008.01.004. Epub 2008 Mar 14. Eur J Paediatr Neurol. 2009. PMID: 18343174 Clinical Trial.

6

Emergency management of febrile status epilepticus: results of the FEBSTAT study.

Seinfeld S, Shinnar S, Sun S, Hesdorffer DC, Deng X, Shinnar RC, O'Hara K, Nordli DR Jr, Frank LM, Gallentine W, Moshé SL, Pellock JM; FEBSTAT study team. Seinfeld S, et al. Epilepsia. 2014 Mar;55(3):388-95. doi: 10.1111/epi.12526. Epub 2014 Feb 6. Epilepsia. 2014. PMID: 24502379 Free PMC article.

7

Antiepileptic drugs: expanded options and improved tolerance.

Leszczyszyn DJ, Pellock JM. Leszczyszyn DJ, et al. Among authors: pellock jm. Am J Electroneurodiagnostic Technol. 2004 Jun;44(2):75-94. Am J Electroneurodiagnostic Technol. 2004. PMID: 15328704 Review.

8

Registry initiated to characterize vision loss associated with vigabatrin therapy.

Pellock JM, Faught E, Sergott RC, Shields WD, Burkhart GA, Krauss GL, Foroozan R, Wesche DL, Weinberg MA. Pellock JM, et al. Epilepsy Behav. 2011 Dec;22(4):710-7. doi: 10.1016/j.yebeh.2011.08.034. Epub 2011 Oct 5. Epilepsy Behav. 2011. PMID: 21978471

9

Use of computer simulations to test the concept of dose forgiveness in the era of extended-release (XR) drugs.

Pellock JM, Brittain ST. Pellock JM, et al. Epilepsy Behav. 2016 Feb;55:21-3. doi: 10.1016/j.yebeh.2015.11.029. Epub 2015 Dec 24. Epilepsy Behav. 2016. PMID: 26724400 Free article.

10

Clinical utility of topiramate extended-release capsules (USL255): Bioequivalence of USL255 sprinkled and intact capsule in healthy adults and an in vitro evaluation of sprinkle delivery via enteral feeding tubes.

Clark AM, Pellock JM, Holmay M, Anders B, Cloyd J. Clark AM, et al. Among authors: pellock jm. Epilepsy Behav. 2016 Apr;57(Pt A):105-110. doi: 10.1016/j.yebeh.2016.01.034. Epub 2016 Mar 2. Epilepsy Behav. 2016. PMID: 26943947 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page